MedTrace Logo

D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy

NCT03280641 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1194

Last updated 2017-09-12

No results posted yet for this study

Summary

This is a sigle-center, prospective study to evaluate the role of D-Dimer testing in patients with atrial fibrillation receiving Dabigatran or warfarin anticoagulation therapy.

Conditions

Interventions

DRUG

Dabigatran Etexilate 110mg

Dabigatran Etexilate 110mg, BID

DRUG

Warfarin Sodium

Target INR:1.6-3.0

Sponsors & Collaborators

  • Wuhan Asia Heart Hospital

    lead OTHER

Principal Investigators

  • Litao ZHANG, MD · Wuhan Asia Heart Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-09
Primary Completion
2017-07-30
Completion
2017-09-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03280641 on ClinicalTrials.gov